U.S. flag

An official website of the United States government

NM_170665.4(ATP2A2):c.2104G>A (p.Asp702Asn) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Dec 12, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003557787.4

Allele description [Variation Report for NM_170665.4(ATP2A2):c.2104G>A (p.Asp702Asn)]

NM_170665.4(ATP2A2):c.2104G>A (p.Asp702Asn)

Gene:
ATP2A2:ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q24.11
Genomic location:
Preferred name:
NM_170665.4(ATP2A2):c.2104G>A (p.Asp702Asn)
HGVS:
  • NC_000012.12:g.110342234G>A
  • NG_007097.2:g.65608G>A
  • NM_001413013.1:c.1999G>A
  • NM_001413014.1:c.2104G>A
  • NM_001413015.1:c.1729G>A
  • NM_001681.4:c.2104G>A
  • NM_170665.4:c.2104G>AMANE SELECT
  • NP_001399942.1:p.Asp667Asn
  • NP_001399943.1:p.Asp702Asn
  • NP_001399944.1:p.Asp577Asn
  • NP_001672.1:p.Asp702Asn
  • NP_733765.1:p.Asp702Asn
  • NC_000012.11:g.110780039G>A
  • NM_170665.3:c.2104G>A
Protein change:
D577N
Links:
dbSNP: rs2548563282
NCBI 1000 Genomes Browser:
rs2548563282
Molecular consequence:
  • NM_001413013.1:c.1999G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001413014.1:c.2104G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001413015.1:c.1729G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001681.4:c.2104G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_170665.4:c.2104G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004296226Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 17, 2023)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

SCV006088090GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Dec 12, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Spectrum of novel ATP2A2 mutations in patients with Darier's disease.

Sakuntabhai A, Burge S, Monk S, Hovnanian A.

Hum Mol Genet. 1999 Sep;8(9):1611-9.

PubMed [citation]
PMID:
10441323

Identification of mutations in the ATP2A2 gene in patients with Darier's disease from Hungary.

Rácz E, Csikós M, Kornsée Z, Horváth A, Kárpáti S.

Exp Dermatol. 2004 Jun;13(6):396-9.

PubMed [citation]
PMID:
15186327
See all PubMed Citations (6)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004296226.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 702 of the ATP2A2 protein (p.Asp702Asn). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of Darier disease (PMID: 10441323, 15186327, 19528419; Invitae). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ATP2A2 protein function. Experimental studies have shown that this missense change affects ATP2A2 function (PMID: 12975374, 16766529). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From GeneDx, SCV006088090.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Published functional studies demonstrate severe loss of enzyme activity and impaired protein function (PMID: 12975374); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; This variant is associated with the following publications: (PMID: 12072062, 23356892, 28035777, 26471493, 15186327, 19528419, 30345710, 1831454, 16766529, 12975374, 10441323)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 29, 2025